By Arash Emamzadeh — 2021
The efficacy of two forms of ketamine treatments for depression is compared.
Read on www.psychologytoday.com
CLEAR ALL
Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.
1
For the owners of Magnolia Wellness, LLC, mental health is more than just a brain issue. Rather, say Gizelle Tircuit and her daughter Janelle Posey-Green, emotional wellness goes far beyond what’s inside someone’s head, encompassing their body, their community, their culture and more.
I believe that social workers need to focus on that which we are trained to do: extend civic love and compassion to the client, staring where he or she is. We are not wed to the medical model; social work is ecological, psychosocial, and systems oriented.
Like most people of color in the United States, psychotherapist and researcher Monnica Williams has experienced myriad forms of racism. Early in her career, understanding its effects on her mind and body motivated her to help clients address their own racial trauma in therapy.
We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.
These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.
2
A recent study found that even a single positive psychedelic experience may ease mental health symptoms associated with racial trauma experienced by Black, Indigenous, and people of color (BIPOC).
Most genetic studies completely ignore the science of epigenetics, which is how the environment actually turns certain genes on or off.
3
The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry
Williams is the co-lead author of a recent retrospective study that found those who tried doses of psilocybin (more commonly known as magic mushrooms), LSD, or MDMA (the pure substance found in Ecstasy or Molly) reported a decrease in trauma symptoms, depression and anxiety after 30 days.